The new line features advanced isolator technology to deliver enhanced sterility assurance, throughput and operational precision
Furthering?U.S.-based?pharmaceutical?capacity?to?produce?critical respiratory medicines?
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
The expansion will significantly enhance AbbVie’s ability to meet growing global demand for biologics, particularly in oncology and immunology
The new site enables end-to-end production of viral vector gene therapies
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
_LOGO_256_384.jpg){kind=logo}
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Subscribe To Our Newsletter & Stay Updated
